CYP3A5 GENOTYPE IS NOT RELATED TO THE INTRA-PATIENT VARIABILITY OF TACROLIMUS CLEARANCE IN RENAL TRANSPLANT RECIPIENTS

被引：0
|
作者：
Spierings, Natalia M. K. [1 ]
Pashaee, Nilufar [2 ]
Bouamar, Rachida [2 ]
Hesselink, Dennis A. [3 ]
Roodnat, Joke I. [3 ]
van Schaik, Ron H. N.
Weimar, Willem [3 ]
Holt, David W. [1 ]
MacPhee, Iain A. M. [1 ]
van Gelder, Teun [2 ,3 ]
机构：
[1] Univ London, Div Clin Sci, London, England
[2] Erasmus MC, Clin Pharmacol Unit, Rotterdam, Netherlands
[3] Erasmus MC, Div Nephrol & Renal Transplantat, Rotterdam, Netherlands
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [1] CYP3A5 genotype is not related to the intra-patient variability of tacrolimus clearance
    Bouamar, R.
    Pashaee, N.
    Hesselink, D.
    Roodnat, J.
    van Schaik, R.
    Weimar, W.
    van Gelder, T.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 506 - 506
  • [2] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331
  • [3] CYP3A5 Genotype Is Not Related to the Intrapatient Variability of Tacrolimus Clearance
    Pashaee, Nilufar
    Bouamar, Rachida
    Hesselink, Dennis A.
    Roodnat, Joke I.
    van Schaik, Ron H. N.
    Weimar, Willem
    van Gelder, Teun
    THERAPEUTIC DRUG MONITORING, 2011, 33 (03) : 369 - 371
  • [4] A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients
    Barry, Arden
    Levine, Marc
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 708 - 714
  • [5] Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients
    Seibert, Stephan R.
    Schladt, David P.
    Wu, Baolin
    Guan, Weihua
    Dorr, Casey
    Remmel, Rory P.
    Matas, Arthur J.
    Mannon, Roslyn B.
    Israni, Ajay K.
    Oetting, William S.
    Jacobson, Pamala A.
    CLINICAL TRANSPLANTATION, 2018, 32 (12)
  • [6] Natural Evolution Of Tacrolimus Intra-patient Variability Among Renal Transplant Recipients
    Zheng, K.
    Tremblay, S.
    Ejaz, N. S.
    Wilson, N. K.
    Hoffman, K.
    Kaur, T.
    Anand, M.
    Woodle, E. S.
    Alloway, R. R.
    Kaiser, T. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 925 - 926
  • [7] THE ASSOCIATION OF BODYWEIGHT AND CYP3A5 GENOTYPE WITH TACROLIMUS TROUGH LEVEL IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Tang, Jang-Tao
    Shi, Yun-Ying
    Li, Yi
    Yan, Lin
    Wang, Ting-Li
    Bai, Yang-Juan
    Zou, Yuan-Gao
    Tao, Ye
    Wang, Lan-Lan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 415 - 416
  • [8] Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus
    Chen, J. S.
    Li, L. S.
    Cheng, D. R.
    Ji, S. M.
    Sun, Q. Q.
    Cheng, Z.
    Wen, J. Q.
    Sha, G. Z.
    Liu, Z. H.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1557 - 1561
  • [9] Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
    de Jonge, Hylke
    de Loor, Henriette
    Verbeke, Krisitin
    Vanrenterghem, Yves
    Kuypers, Dirk R. J.
    PHARMACOGENOMICS, 2013, 14 (12) : 1467 - 1480
  • [10] Natural Course Of Tacrolimus Intra-patient Variability In Liver Transplant Recipients
    Wilson, N.
    Tremblay, S.
    Ejaz, N. S.
    Zheng, K.
    Garrett, J.
    Shah, S. A.
    Alloway, R. R.
    Kaiser, T. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1079 - 1079
12345